Correlation Between Imugene and Predictive Discovery

Can any of the company-specific risk be diversified away by investing in both Imugene and Predictive Discovery at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Imugene and Predictive Discovery into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Imugene and Predictive Discovery, you can compare the effects of market volatilities on Imugene and Predictive Discovery and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Imugene with a short position of Predictive Discovery. Check out your portfolio center. Please also check ongoing floating volatility patterns of Imugene and Predictive Discovery.

Diversification Opportunities for Imugene and Predictive Discovery

-0.25

Correlation Coefficient

Imugene  Predictive Discovery

Very good diversification

The 3 months correlation between Imugene and Predictive is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Imugene and Predictive Discovery in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Discovery and Imugene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Imugene are associated (or correlated) with Predictive Discovery. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Discovery has no effect on the direction of Imugene i.e., Imugene and Predictive Discovery go up and down completely randomly.

Pair Corralation between Imugene and Predictive Discovery

Assuming the 90 days trading horizon Imugene is expected to under-perform the Predictive Discovery. But the stock apears to be less risky and, when comparing its historical volatility, Imugene is 1.1 times less risky than Predictive Discovery. The stock trades about -0.19 of its potential returns per unit of risk. The Predictive Discovery is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  22.00  in Predictive Discovery on September 3, 2024 and sell it today you would earn a total of  3.00  from holding Predictive Discovery or generate 13.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Imugene  vs.  Predictive Discovery

Imugene

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Imugene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Predictive Discovery

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Predictive Discovery are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain forward indicators, Predictive Discovery unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Imugene and Predictive Discovery

The main advantage of trading using opposite Imugene and Predictive Discovery positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Imugene position performs unexpectedly, Predictive Discovery can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Discovery will offset losses from the drop in Predictive Discovery's long position.

The idea behind Imugene and Predictive Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.